362 related articles for article (PubMed ID: 11176481)
1. Primary treatment of condylomata acuminata with viable bacillus Calmette-Guerin.
Böhle A; Büttner H; Jocham D
J Urol; 2001 Mar; 165(3):834-6. PubMed ID: 11176481
[TBL] [Abstract][Full Text] [Related]
2. Treatment of recurrent penile condylomata acuminata with external application and intraurethral instillation of bacillus Calmette-Guerin.
Böhle A; Doehn C; Kausch I; Jocham D
J Urol; 1998 Aug; 160(2):394-6. PubMed ID: 9679885
[TBL] [Abstract][Full Text] [Related]
3. Application of viable bacille Calmette-Guérin topically as a potential therapeutic modality in condylomata acuminata: a placebo-controlled study.
Metawea B; El-Nashar AR; Kamel I; Kassem W; Shamloul R
Urology; 2005 Feb; 65(2):247-50. PubMed ID: 15708031
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of endoscopic therapy of anal canal condylomata acuminata with podophyllotoxin.
Tzathas C; Stavrianeas NG; Triantafyllou K; Triantafyllou G; Ladas SD
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):364-7. PubMed ID: 17309460
[TBL] [Abstract][Full Text] [Related]
5. Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).
de Reijke TM; Kurth KH; Sylvester RJ; Hall RR; Brausi M; van de Beek K; Landsoght KE; Carpentier P;
J Urol; 2005 Feb; 173(2):405-9. PubMed ID: 15643181
[TBL] [Abstract][Full Text] [Related]
6. Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata.
Wang XL; Wang HW; Wang HS; Xu SZ; Liao KH; Hillemanns P
Br J Dermatol; 2004 Oct; 151(4):880-5. PubMed ID: 15491431
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.
Yossepowitch O; Eggener SE; Bochner BH; Donat SM; Herr HW; Dalbagni G
J Urol; 2006 Aug; 176(2):482-5. PubMed ID: 16813873
[TBL] [Abstract][Full Text] [Related]
8. Treatment of common and plane warts in children with topical viable Bacillus Calmette-Guerin.
Salem A; Nofal A; Hosny D
Pediatr Dermatol; 2013; 30(1):60-3. PubMed ID: 22958215
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up.
Järvinen R; Kaasinen E; Sankila A; Rintala E;
Eur Urol; 2009 Aug; 56(2):260-5. PubMed ID: 19395154
[TBL] [Abstract][Full Text] [Related]
10. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
Lerner SP; Tangen CM; Sucharew H; Wood D; Crawford ED
J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
[TBL] [Abstract][Full Text] [Related]
11. Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer.
Cheng CW; Chan SF; Chan LW; Chan CK; Ng CF; Cheung HY; Chan SY; Wong WS; Lai FM; To KF; Li ML
Int J Urol; 2005 May; 12(5):449-55. PubMed ID: 15948743
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of patients with Stage T1 high-grade transitional cell carcinoma managed by Bacille Calmette-Guérin immunotherapy.
Margel D; Tal R; Golan S; Kedar D; Engelstein D; Baniel J
Urology; 2007 Jan; 69(1):78-82. PubMed ID: 17270621
[TBL] [Abstract][Full Text] [Related]
13. Defining bacillus Calmette-Guerin refractory superficial bladder tumors.
Herr HW; Dalbagni G
J Urol; 2003 May; 169(5):1706-8. PubMed ID: 12686813
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of external ano-genital condylomata with 0.5% podophyllotoxin].
Aynaud O; Tranbaloc P
Contracept Fertil Sex; 1995 Feb; 23(2):127-30. PubMed ID: 7894544
[TBL] [Abstract][Full Text] [Related]
15. [Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes].
Iturralde Codina A; Beyríe Tamayo W; Gozá León F; Muñoz YI
Arch Esp Urol; 2004; 57(6):606-18. PubMed ID: 15382436
[TBL] [Abstract][Full Text] [Related]
16. The effect of ofloxacin on bacillus calmette-guerin induced toxicity in patients with superficial bladder cancer: results of a randomized, prospective, double-blind, placebo controlled, multicenter study.
Colombel M; Saint F; Chopin D; Malavaud B; Nicolas L; Rischmann P
J Urol; 2006 Sep; 176(3):935-9. PubMed ID: 16890660
[TBL] [Abstract][Full Text] [Related]
17. Treatment of vaginal condylomata acuminata by weekly topical application of 5-fluorouracil.
Krebs HB
Obstet Gynecol; 1987 Jul; 70(1):68-71. PubMed ID: 3601270
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonic technology: a new treatment option for anal condylomata acuminata.
Colombo-Benkmann M; Tübergen D; Buchweitz O; Senninger N
Dis Colon Rectum; 2008 Nov; 51(11):1681-5. PubMed ID: 18484137
[TBL] [Abstract][Full Text] [Related]
19. 5-Fluoro-uracil cream in the successful treatment of therapeutically refractory condylomata acuminata of the urinary meatus.
von Krough G
Acta Derm Venereol; 1976; 56(4):297-301. PubMed ID: 60026
[TBL] [Abstract][Full Text] [Related]
20. Single dose intralesional immunotherapy with BCG of medically resistant condylomata acuminata of the penis: report of two cases.
Gupta SK
Int J Dermatol; 2016 May; 55(5):583-6. PubMed ID: 26341833
[No Abstract] [Full Text] [Related]
[Next] [New Search]
